Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Albert

Showing results (301-310 of 437) with videos related to

Pageof 44
Sort By:
Journal of Clinical Immunology|November 13, 2014
Hematopoietic Stem Cell Transplantation for X-Linked Thrombocytopenia With Mutations in the WAS geneKoichi Oshima, Kohsuke Imai, Michael H Albert, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2011
Discovery of potent and selective thienopyrimidine inhibitors of Aurora kinasesWilliam J McClellan, Yujia Dai, Cele Abad-Zapatero, et al.
The Journal of Allergy and Clinical Immunology|March 21, 2015
B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndromeMaria Carmina Castiello, Samantha Scaramuzza, Francesca Pala, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 4, 2009
Effect of the multitargeted receptor tyrosine kinase inhibitor, ABT-869 [N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea], on blood pressure in conscious rats and mice: reversal with antihypertensive agents and effect on tumor growth inhibitionPamela H Franklin, Patricia N Banfor, Paul Tapang, et al.
Blood Advances|July 10, 2024
Permissible HLA mismatches in 9/10 unrelated donor pediatric stem cell transplants using HLA-EMMA: an EBMT Inborn Errors Working Party studyErik G J von Asmuth, Fleur Hiensch, Sebastiaan Heidt, et al.
Plos One|May 19, 2011
PRL-3, a metastasis associated tyrosine phosphatase, is involved in FLT3-ITD signaling and implicated in anti-AML therapyJianbiao Zhou, Chonglei Bi, Wee-Joo Chng, et al.
The Pharmacogenomics Journal|February 4, 2009
Identification of genes that confer tumor cell resistance to the aurora B kinase inhibitor, AZD1152J Guo, M G Anderson, P Tapang, et al.
Blood|January 16, 2009
Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AMLJianbiao Zhou, Chonglei Bi, Jasinghe V Janakakumara, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2012
Exploration of diverse hinge-binding scaffolds for selective Aurora kinase inhibitorsZhiqin Ji, Yujia Dai, Cele Abad-Zapatero, et al.
Pediatric Hematology and Oncology|August 18, 2012
Clinical and immunological correction of DOCK8 deficiency by allogeneic hematopoietic stem cell transplantation following a reduced toxicity conditioning regimenHeidrun Boztug, Cäcilia Karitnig-Weiß, Bernd Ausserer, et al.
Pageof 44

Showing results (301-310 of 437) with videos related to

Sort By:
Pageof 44
Journal of Clinical Immunology|November 13, 2014
Hematopoietic Stem Cell Transplantation for X-Linked Thrombocytopenia With Mutations in the WAS geneKoichi Oshima, Kohsuke Imai, Michael H Albert, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2011
Discovery of potent and selective thienopyrimidine inhibitors of Aurora kinasesWilliam J McClellan, Yujia Dai, Cele Abad-Zapatero, et al.
The Journal of Allergy and Clinical Immunology|March 21, 2015
B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndromeMaria Carmina Castiello, Samantha Scaramuzza, Francesca Pala, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 4, 2009
Effect of the multitargeted receptor tyrosine kinase inhibitor, ABT-869 [N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea], on blood pressure in conscious rats and mice: reversal with antihypertensive agents and effect on tumor growth inhibitionPamela H Franklin, Patricia N Banfor, Paul Tapang, et al.
Blood Advances|July 10, 2024
Permissible HLA mismatches in 9/10 unrelated donor pediatric stem cell transplants using HLA-EMMA: an EBMT Inborn Errors Working Party studyErik G J von Asmuth, Fleur Hiensch, Sebastiaan Heidt, et al.
Plos One|May 19, 2011
PRL-3, a metastasis associated tyrosine phosphatase, is involved in FLT3-ITD signaling and implicated in anti-AML therapyJianbiao Zhou, Chonglei Bi, Wee-Joo Chng, et al.
The Pharmacogenomics Journal|February 4, 2009
Identification of genes that confer tumor cell resistance to the aurora B kinase inhibitor, AZD1152J Guo, M G Anderson, P Tapang, et al.
Blood|January 16, 2009
Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AMLJianbiao Zhou, Chonglei Bi, Jasinghe V Janakakumara, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2012
Exploration of diverse hinge-binding scaffolds for selective Aurora kinase inhibitorsZhiqin Ji, Yujia Dai, Cele Abad-Zapatero, et al.
Pediatric Hematology and Oncology|August 18, 2012
Clinical and immunological correction of DOCK8 deficiency by allogeneic hematopoietic stem cell transplantation following a reduced toxicity conditioning regimenHeidrun Boztug, Cäcilia Karitnig-Weiß, Bernd Ausserer, et al.
Pageof 44